Related references
Note: Only part of the references are listed.Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer
Elisabetta Munzone et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer
Katharina Heusinger et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Prognostic Value of Estrogen Receptor α and Progesterone Receptor Conversion in Distant Breast Cancer Metastases
Laurien D. C. Hoefnagel et al.
CANCER (2012)
The biology of progesterone receptor in the normal mammary gland and in breast cancer
Alison E. Obr et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
Mohammed A. Aleskandarany et al.
BREAST CANCER RESEARCH (2012)
Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain
Renata Duchnowska et al.
BREAST CANCER RESEARCH (2012)
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Peter A. Fasching et al.
BMC CANCER (2011)
Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies
Quinci Romero et al.
BMC CANCER (2011)
HER2 status in a population-derived breast cancer cohort: discordances during tumor progression
Ulla Wilking et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Stability of Estrogen Receptor Status in Breast Carcinoma A Comparison Between Primary and Metastatic Tumors With Regard to Disease Course and Intervening Systemic Therapy
Yun Gong et al.
CANCER (2011)
Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition
Masakazu Toi et al.
CANCER SCIENCE (2011)
HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient Care
Alessandra Fabi et al.
CLINICAL CANCER RESEARCH (2011)
ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium
Daniel G. Holland et al.
EMBO MOLECULAR MEDICINE (2011)
ZNF703 gene amplification at 8p12 specifies luminal B breast cancer
Fabrice Sircoulomb et al.
EMBO MOLECULAR MEDICINE (2011)
Zurich Consensus: Statement of German Experts on St. Gallen Conference 2011 on Breast Cancer (Zurich 2011)
M. Untch et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2011)
Breast Cancer 2011-New Aspects
S. Kuemmel et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2011)
Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial
Andre Mattar et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
Jack Cuzick et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
Mitch Dowsett et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Comparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: clinical implications of progesterone receptor loss
Giuseppe Bogina et al.
VIRCHOWS ARCHIV (2011)
Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis
Reiki Nishimura et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2011)
Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis
Bhumsuk Keam et al.
BREAST CANCER RESEARCH (2011)
Who is in the driver's seat in 8p12 amplifications? ZNF703 in luminal B breast tumors
Alexey V. Bazarov et al.
BREAST CANCER RESEARCH (2011)
Practical prognostic index for patients with metastatic recurrent breast cancer: retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo Register
Javier Puente et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
New Concepts for Targeted Systemic Therapy in Breast Cancer
C. Liedtke et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2010)
Breast Cancer Therapy - A State of the Art Review
P. A. Fasching et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2010)
Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer
Abigail S. Caudle et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Ki67 in breast cancer: prognostic and predictive potential
Rinat Yerushalmi et al.
LANCET ONCOLOGY (2010)
Receptor conversion in distant breast cancer metastases
Laurien D. C. Hoefnagel et al.
BREAST CANCER RESEARCH (2010)
The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
Robin L. Jones et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Prognostic factors in 1038 women with metastatic breast cancer
R. Largillier et al.
ANNALS OF ONCOLOGY (2008)
Impact of metastatic estrogen receptor and progesterone receptor status on survival
EE Lower et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases
A Skildum et al.
MOLECULAR ENDOCRINOLOGY (2005)
Survival of patients with metastatic breast carcinoma - Importance of prognostic markers of the primary tumor
J Chang et al.
CANCER (2003)
Progesterone receptor status of breast cancer metastases
M Brankovic-Magic et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2002)
Patterns of HER-2/neu amplification and overexpression in primary and metastatic breast cancer
R Simon et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy
M Ryberg et al.
ANNALS OF ONCOLOGY (2001)
Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer
M Robain et al.
EUROPEAN JOURNAL OF CANCER (2000)
Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis
EF Solomayer et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)
Share Paper
